These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 14508366

  • 21. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 22. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 23. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
    McAlister V, Grant D, Roy A, Yilmaz Z, Ghent C, Wall W.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 2):1400-1. PubMed ID: 8442154
    [No Abstract] [Full Text] [Related]

  • 24. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 25. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov 15; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 26. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
    Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010
    [Abstract] [Full Text] [Related]

  • 27. Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantation.
    Subklewe M, Marquis R, Choquet S, Leblond V, Garnier JL, Hetzer R, Swinnen LJ, Oertel S, Papp-Vary M, Gonzalez-Barca E, Hepkema BG, Schoenemann C, May J, Pezzutto A, Riess H.
    Transplantation; 2006 Oct 27; 82(8):1093-100. PubMed ID: 17060859
    [Abstract] [Full Text] [Related]

  • 28. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
    Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR.
    Transplantation; 1996 Aug 15; 62(3):370-5. PubMed ID: 8779685
    [Abstract] [Full Text] [Related]

  • 29. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.
    Avolio AW, Agnes S, Barbarino R, Magalini SC, Frongillo F, Pagano L, Larocca LM, Pompili M, Caira M, Sollazzi L, Castagneto M.
    Transplant Proc; 2007 Aug 15; 39(6):1956-60. PubMed ID: 17692665
    [Abstract] [Full Text] [Related]

  • 30. Posttransplant lymphoproliferative disease: a series of 23 cases.
    Martín-Gómez MA, Peña M, Cabello M, Burgos D, Gutierrez C, Sola E, Acedo C, Bailén A, Gonzalez-Molina M.
    Transplant Proc; 2006 Oct 15; 38(8):2448-50. PubMed ID: 17097963
    [Abstract] [Full Text] [Related]

  • 31. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 15; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 32. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J.
    Am J Pathol; 1988 Oct 15; 133(1):173-92. PubMed ID: 2845789
    [Abstract] [Full Text] [Related]

  • 33. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B.
    J Nephrol; 1997 Oct 15; 10(3):136-45. PubMed ID: 9238621
    [Abstract] [Full Text] [Related]

  • 34. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN, Douglas LP, Andreadis C, Arnoldi S, Svoboda J, Kotloff RM, Hadjiliadis D, Sager JS, Woo YJ, Pochettino A, Schuster SJ, Stadtmauer EA, Tsai DE.
    J Heart Lung Transplant; 2007 Aug 15; 26(8):839-44. PubMed ID: 17692789
    [Abstract] [Full Text] [Related]

  • 35. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 36. Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia.
    Buyck HC, Ball S, Junagade P, Marsh J, Chakrabarti S.
    Bone Marrow Transplant; 2009 May 10; 43(10):813-6. PubMed ID: 19104495
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA, Verschuuren EA, Erasmus ME, Hepkema BG, Veeger NJ, Kallenberg CG, van der Bij W.
    Transplantation; 2007 Feb 27; 83(4):433-8. PubMed ID: 17318076
    [Abstract] [Full Text] [Related]

  • 38. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 27; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 39. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
    Dharnidharka VR, Stevens G.
    Pediatr Transplant; 2005 Oct 27; 9(5):622-6. PubMed ID: 16176420
    [Abstract] [Full Text] [Related]

  • 40. Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases.
    Lorenzini S, Andreone P, Gramenzi A, Morelli C, Zinzani PL, Grazi GL, Pileri S, Baccarani M, Tura S, Bernardi M.
    Transplant Proc; 2006 Jun 27; 38(5):1477-80. PubMed ID: 16797338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.